ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial [Yahoo! Finance]
Zynex, Inc. (ZYXI)
NASDAQ:AMEX Investor Relations:
zynexmed.com/ir-overview
Company Research
Source: Yahoo! Finance
David MacLeod at Duke University. NiCO is likely the first Zynex monitoring product to enter a mature and growing market. The product's entry into the market will be enabled by its game-changing capabilities, like advanced laser technology and improved accuracy. Zynex looks forward to the FDA clearance as all the required clinical studies for the NiCO pulse oximeter have been completed. Following the announcement, shares of the company moved north 2.4% and closed at $8.13 on Friday. However, in the year-to-date period, ZYXI shares have lost 23.3% against the industry's 12.9% growth. The S&P 500 increased 28.1% in the same time frame. Meanwhile, ZYXI currently has a market capitalization of $259 million. In the last reported quarter, ZYXI delivered an earnings surprise of 40%. Image Source: Zacks Investment Research The NiCO pulse oximeter from Zynex uses extremely accurate laser technology to monitor blood oxygenation levels directly, unlike other pulse oximeters that solely
Show less
Read more
Impact Snapshot
Event Time:
ZYXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYXI alerts
High impacting Zynex, Inc. news events
Weekly update
A roundup of the hottest topics
ZYXI
News
- Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United StatesPR Newswire
- Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters [Yahoo! Finance]Yahoo! Finance
- Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse OximetersPR Newswire
- Zynex, Inc. (NASDAQ: ZYXI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.MarketBeat
- Zynex Announces Completion of Its Laser Pulse Oximetry Trial [Yahoo! Finance]Yahoo! Finance
ZYXI
Sec Filings
- 12/6/24 - Form 4
- 12/3/24 - Form 4
- 11/18/24 - Form 4
- ZYXI's page on the SEC website